Log In
BCIQ
Print this Print this
 

taspoglutide (R1583, RG1583) (formerly BIM 51077)

  Manage Alerts
Collapse Summary General Information
Company Ipsen Group
DescriptionLong acting glucagon-like peptide-1 (GLP-1) analog
Molecular Target Glucagon-like peptide-1 receptor (GLP-1R) (GLP1R)
Mechanism of ActionGlucagon-like peptide-1 (GLP-1) receptor agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation
PartnerTeijin Pharma Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today